AIM WINNERS & LOSERS: Benchmark up on returns plan; Totally sinks

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

----------

AIM - WINNERS

----------

Cambridge Nutritional Sciences PLC, up 17% at 2.98 pence, 12-month range 2.42p-4.48p. The medical diagnostics firm says a GBP35,000 fine has been imposed on subsidiary Omega Diagnostics. In March, Omega Diagnostics had entered a guilty plea in relation to four breaches of health and safety regulations in 2018. They related to Omega South West, a company previously owned by Omega Diagnostics. The Health & Safety Executive in the UK had brought the legal proceedings. Cambridge Nutritional adds on Friday: "The court found that there was no deliberate breach or flagrant disregard for the law, found no aggravating factors, and found substantial mitigating factors including: no previous convictions, good health and safety record, full cooperation, sincere regret expressed, and breaches over only a narrow window of time. The court also gave full credit for early guilty pleas." The GBP35,000 fine concludes the matter, and Cambridge Nutritional notes the sum "has been fully provided for within the group's existing provisions".

----------

Benchmark Holdings PLC, up 9.1% at 24.00p, 12-month range 16.50p-46.90p. It plans to delist from AIM in London and Euronext Oslo Growth to save costs. The Sheffield, England-based aquaculture biotechnology company cites low liquidity and high costs involved in maintaining the listings, in relation to the size of its group and remaining operations. Benchmark intends to return the vast majority of the net proceeds from the disposal of its Genetics business to shareholders, amounting to GBP95 million via a combination of a tender offer and a planned special dividend. Through the tender offer alone, it plans to return up to GBP56.7 million.

----------

AIM - LOSERS

----------

Totally PLC, down 74% at 0.37p, 12-month range 0.37p-11.50p. It believes a sale of its subsidiaries is "the only realistic route for the group", as it updates on its ongoing strategic review. It warns that there may be no shareholder value and that potential proceeds are "unlikely to be sufficient to meet all future liabilities". The provider of healthcare and wellbeing services says it has received "a number of offers" for business subsidiaries, which it intends to consider and provide further updates "as soon as possible".

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Cambr Nutri Sci